HIGHLIGHTS
- who: Inflammation and collaborators from the The Affiliated Hospital of Medical School, Ningbo University, Ningbo, China have published the paper: Managing Cancer Drug Resistance from the Perspective of Inflammation, in the Journal: Journal of Oncology of 19/09/2022
- what: In this review the authors aim to summarize the underlying molecular mechanisms that participates in cancer drug resistance and discuss the potential clinical strategies targeting to overcome drug resistance. Inflammation-Mediated Changes in Drug Transport and Metabolism Abnormal activation of drug eufb04ux is one of the important reasons for tumor chemotherapy resistance. The authors attempt . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.